Location: Home
  • search
  • go
  • Relate News
  • 2/22/2024New Trade Patterns in 2023: Cars, Chemicals, and China (AEI)
  • 2/19/2024AZ CEO: China Has Become Fundamental Part of Pharma Industry (Bloomber...
  • 2/8/2024Fresh Formulas for Growth: Assessing Asia in the New Year (PharmExec)
  • 2/8/2024China Drug Sales Performance of Top Seven MNC Pharma Cos in 2023
  • 2/6/2024Global Pharma Invests in China on the Strength of a Booming National B...
  • 2/2/2024AmCham China's 26th Annual China Business Climate Survey: US Firms in ...
  • 1/30/20242024 China Medtech Industry Outlook (Simon Kucher)
  • 1/24/2024NMPA Solicits Comments for Draft Doc on Domestic Production Transfer o...
  • 1/22/20242023 Competitiveness Ranking of MNC Pharma Companies in China
  • 1/22/2024Top 20 A Share-listed MedPharm Companies by Market Capitalization in 2...
  • 1/14/2024JPM24: Roche's Pharma BD Chief Explains Renewed ADC Interest But Is Sp...
  • 1/8/2024Foreign Drug Giants Shift Strategy on China Sales as Competition Ramps...
  • 12/26/20232024 Forecast: Big Pharma Reworks China Strategy, And Job Cuts Are Par...
  • 12/22/2023CDE Solicits Comments on the Dossier Requirements for Marketing Regist...
  • 12/19/2023GSK Is Hunting for Deals in China: FT
  • 12/12/2023Pharma MNCs Forge More Local Alliances for Growth in China's Dynamic H...
  • 12/6/2023Asia Toughing Out the Uncertainties and Challenges (BioSpectrum)
  • 11/27/2023AstraZeneca to open Hong Kong R&D centre by late 2024 at earliest with...
  • 11/27/2023Indian Pharma to Benefit amid Big Pharma's China De-Risking
  • 11/24/2023China Biopharma: Charting a Path to Value Creation (McKinsey)
  • 11/22/2023Mixed Q3 For China's Innovative Firms Amid Anti-Graft Campaign (SCRIP ...
  • 11/21/2023MNCs Unveil Initiatives at CIIE to Deepen Connection with Chinese Pati...
  • 11/20/2023Roche to Further Explore China's Personalized Healthcare Market Poten...
  • 11/20/2023Reflections from the 10th BioCentury-BayHelix China Summit, and Other ...
  • 11/13/2023MSD Takes Over AstraZeneca as the Top MNC in China Q3/2023
  • 11/10/2023China's Strength Is Innovation on Innovation, Western Partners Are Lin...
  • 11/9/2023AstraZeneca Reports Q3/2023 Performance with Dwindling China Revenue G...
  • 11/8/2023Chinese and Foreign Pharma, MedTech Firms Discuss Cooperation at CIIE
  • 11/8/2023The Growing Pains of Chinese Biotech (In Vivo Citeline)
  • 11/6/2023486 A-Listed MedPharma Cos Report Performance in First Three Quarters ...
  • Page:2/36 Total number of articles:1059: [First][<<] [1] [2] [3] [4] [5] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group